1.05
price down icon8.70%   -0.10
after-market Dopo l'orario di chiusura: 1.10 0.05 +4.76%
loading
Precedente Chiudi:
$1.15
Aprire:
$1.19
Volume 24 ore:
242.14K
Relative Volume:
1.29
Capitalizzazione di mercato:
$6.22M
Reddito:
-
Utile/perdita netta:
$-15.52M
Rapporto P/E:
-0.0565
EPS:
-18.58
Flusso di cassa netto:
$-16.61M
1 W Prestazione:
+1.45%
1M Prestazione:
+6.92%
6M Prestazione:
+30.43%
1 anno Prestazione:
-84.09%
Intervallo 1D:
Value
$1.01
$1.19
Intervallo di 1 settimana:
Value
$1.01
$1.20
Portata 52W:
Value
$0.702
$20.16

Revelation Biosciences Inc Stock (REVB) Company Profile

Name
Nome
Revelation Biosciences Inc
Name
Telefono
650-800-3717
Name
Indirizzo
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Name
Dipendente
9
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
REVB's Discussions on Twitter

Confronta REVB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
REVB
Revelation Biosciences Inc
1.05 6.81M 0 -15.52M -16.61M -18.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Revelation Biosciences Inc Borsa (REVB) Ultime notizie

pulisher
Dec 11, 2025

Revelation Biosciences sets warrant expiration after stockholder approval - Investing.com

Dec 11, 2025
pulisher
Dec 04, 2025

Why Revelation Biosciences Inc. stock remains a top recommendationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - azcentral.com and The Arizona Republic

Dec 04, 2025
pulisher
Dec 04, 2025

Revelation Biosciences shareholders approve warrant issuance and meeting adjournment By Investing.com - Investing.com Canada

Dec 04, 2025
pulisher
Dec 03, 2025

Revelation Biosciences, Inc. (REVB) -5.1% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph

Dec 03, 2025
pulisher
Dec 03, 2025

Revelation Biosciences shareholders approve warrant issuance and meeting adjournment - Investing.com

Dec 03, 2025
pulisher
Dec 02, 2025

Revelation Biosciences (REVB) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Revelation Biosciences (NASDAQ: REVB) secures quorum ahead of Dec. 3 vote, notes $9.6M proceeds - Stock Titan

Dec 01, 2025
pulisher
Nov 29, 2025

Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN

Nov 29, 2025
pulisher
Nov 29, 2025

Revelation Biosciences (NASDAQ:REVB) Shares Up 2.4% – Here’s Why - Defense World

Nov 29, 2025
pulisher
Nov 28, 2025

Revelation Biosciences, Inc. (REVB) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 28, 2025
pulisher
Nov 27, 2025

Earnings Flash (REVB) Revolution Beauty Group Reports Fiscal H1 Revenue GBP49.4M - marketscreener.com

Nov 27, 2025
pulisher
Nov 22, 2025

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The State Journal-Register

Nov 22, 2025
pulisher
Nov 22, 2025

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - The Courier-Journal

Nov 22, 2025
pulisher
Nov 21, 2025

Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com Australia

Nov 21, 2025
pulisher
Nov 20, 2025

Revelation Says On Track for FDA Meeting Later This Year - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Nov 18, 2025

Revelation Biosciences Inc Azioni (REVB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):